GCM
AMGN icon

Glenview Capital Management’s Amgen AMGN Stock Holding History

Glenview Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-134,645
Closed -$30.3M – 61
2021
Q4 		$30.3M Buy
134,645
+28,775
+27% +$6.07M 0.65% 41
2021
Q3 		$22.5M Buy
105,870
+33,557
+46% +$7.72M 0.41% 48
2021
Q2 		$17.6M Buy
+72,313
New +$17.8M 0.29% 51
2021
Q1 		– Sell
-141,474
Closed -$32.5M – 64
2020
Q4 		$32.5M Buy
141,474
+96,171
+212% +$22.2M 0.75% 34
2020
Q3 		$11.5M Buy
+45,303
New +$11.2M 0.36% 36

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Glenview Capital Management's AMGN Position: Q1 2022 in Review

Glenview Capital Management sold out of Amgen (AMGN) in Q1 2022, closing a stake of 134,645 shares — an estimated $30.3M sold.

Glenview Capital Management first reported a position in AMGN in Q3 2020 and held it in 5 quarters. The position peaked at $32.5M in Q4 2020. 2,336 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Glenview Capital Management reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
  • Glenview Capital Management sold 134,645 Amgen shares in Q1 2022, an estimated $30.3M.
  • Glenview Capital Management first reported a position in Amgen in Q3 2020 and held it in 5 quarters.
  • Glenview Capital Management's Amgen position peaked at $32.5M in Q4 2020.
  • 2,336 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Glenview Capital Management's 13F filing for Q1 2022, filed 16 May 2022.